On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
All content for Brains Behind AI is the property of Ari Yacobi and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
Aryballe: Sam Guilaumé on combining biochemistry and AI to enable digitalization of smell
Brains Behind AI
31 minutes
4 years ago
Aryballe: Sam Guilaumé on combining biochemistry and AI to enable digitalization of smell
We had the opportunity to speak with the CEO of Aryballe, Sam Guilaumé. Aryballeis a unique Artificial Intelligence company that combines biochemistry, advanced optics and machine learning to mimic the human sense of smell, one of the more complicated, if not the toughest, sense to duplicate. Aryballe is also using Artificial Intelligence technologies to allow certain senses to convey a particular emotion, which assists brands and companies to truly create an overall five-sensory experience. ...
Brains Behind AI
On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
